feed,title,long_url,short_url
Benzinga,Hello Shares Dive Post Dismal Q1 Guidance Amid China's Domestic Tech Crackdown,https://benzinga.com/news/earnings/22/03/26273396/hello-shares-dive-post-dismal-q1-guidance-amid-chinas-domestic-tech-crackdown,https://bit.ly/3IDWMvr
Benzinga,"The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL",https://benzinga.com/general/biotech/22/03/26273116/the-daily-biotech-pulse-novartis-prostate-cancer-drug-lands-fda-approval-ligand-announces-spac-de,https://bit.ly/3uopHP8
